Global Oncology Pipeline Medical Affairs Lead

AbbVie; New Jersey; Hybrid; USD 180,000 - 260,000; Full time

Benefits offered by this job

Comprehensive benefits package

Long-term incentive programs

Paid time off

Job summary

AbbVie in New Jersey is seeking a seasoned Medical Affairs leader to shape the therapeutic area strategy across oncology/hematology, guiding lifecycle plans and evidence generation.

You will lead cross-functional teams, integrate payor and patient insights, and drive differentiation of medical, value and evidence strategies for US and international markets, from discovery through pre-launch.

Qualifications

• M.D. or equivalent advanced degree in oncology/hematology.
• 15+ years of pharma/biotech experience focused on oncology.
• Proven leadership in medical affairs with cross-functional teams.
• Strong knowledge of solid tumor biology, trial design, biomarkers.
• Excellent communication to technical and non-technical stakeholders.

Responsibilities

• Lead and oversee pipeline medical strategy for US and international markets.
• Drive differentiation of medical, value and evidence strategy.
• Coordinate across TAs to align pipeline strategy.
• Incorporate HCP, patients, payor insights into development programs.
• Represent medical affairs in governance and decision making.
• Manage resources and handover to launch teams.
• Lead Integrated Evidence Planning and collaboration.
• Define enterprise research strategy in US and affiliates.
• Coordinate with US Medical Engagement to track KPIs.

Skills

Leadership experience

Cross-functional collaboration

Strategic planning

Executive communication

Travel readiness

Education

MD or equivalent advanced degree in oncology/hematology

Job description

AbbVie in New Jersey is seeking a seasoned Medical Affairs leader to shape the therapeutic area strategy across oncology/hematology, guiding lifecycle plans and evidence generation.

You will lead cross-functional teams, integrate payor and patient insights, and drive differentiation of medical, value and evidence strategies for US and international markets, from discovery through pre-launch.